Key result
Arg389 homozygotes were less likely to have ventricular extrasystoles during exercise than Gly389 carriers (OR 0.68; 95% CI 0.51-0.91; P=0.009).
Why the study?
Do polymorphisms in ADRB1 and GNAS1 modulate heart rate and blood pressure responses during an exercise stress test?
Observational (n=890)
Do polymorphisms in ADRB1 and GNAS1 modulate heart rate and blood pressure responses during an exercise stress test?
Odds Ratio: 0.68 (95% CI 0.51–0.91)
p-value: p=0.009
Genetic polymorphisms in ADRB1 and GNAS1 have minor, likely clinically insignificant modulatory effects on hemodynamics during exercise testing.
Does not support ADRB1 genotyping for exercise testing; hypothesis-generating for arrhythmia modulation by beta-receptor variants.
We tested whether the Arg389Gly and Ser49Gly polymorphisms of the beta1-adrenergic receptor gene ADRB1 and the T393C polymorphism of the G protein alpha-subunit gene GNAS1 modulate heart rate (HR) and blood pressure responses during an exercise stress test. The study population comprised 890 participants (563 men and 327 women, mean age 58.1 +/- 12.6 yr) of the Finnish Cardiovascular Study. Their HR, systolic (SAP), and diastolic arterial pressures (DAP) at rest, during exercise, and 4 min after the test were measured and analyzed by repeated-measurement ANOVA (RANOVA). Genotypes were detected by TaqMan 5' nuclease assay. In all subjects, and in men and women separately, the T393C of GNAS1 was the only polymorphism with genotype x time interaction in HR over the three study phases (P = 0.04, RANOVA). None of the polymorphisms presented genotype x time interaction in SAP or DAP responses (P > 0.10, RANOVA). In all subjects at rest, the Ser49Gly polymorphism of ADRB1 tended (P = 0.06, ANOVA) to differentiate HR. Arg389Gly polymorphism of ADRB1 affected maximal SAP during exercise (P = 0.04, ANOVA) and the change in SAP from rest to maximal (P = 0.03, ANOVA). Arg389 homozygotes, particularly men, were less likely to have ventricular extrasystoles during the exercise (odds ratio = 0.68, 95% confidence interval = 0.51-0.91, P = 0.009, and odds ratio = 0.60, 95% confidence interval = 0.42-0.86, P = 0.006, respectively) than did Gly389 carriers. In conclusion, polymorphisms examined appear to have modulatory effects on hemodynamics in a clinical exercise test setting. However, the effects in absolute numbers were minor and clinically possibly insignificant.
No takes yet. Share an insight, caveat, or question.
Nieminen et al. (2005) reported an observational. ADRB1 and GNAS1 gene polymorphisms vs. Alternative genotypes was evaluated on Ventricular extrasystoles during exercise (OR 0.68, 95% CI 0.51-0.91, p=0.009). Arg389 homozygotes were less likely to have ventricular extrasystoles during exercise than Gly389 carriers (OR 0.68; 95% CI 0.51-0.91; P=0.009).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: